Herbert J. Conrad is Director at SAVIENT PHARMACEUTICALS INC (SVNT). They have made 12 open-market trades across 3 companies since 2007, most recently 2022-06-22.
CIK 0001218815
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $154K since 2016, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MTNB | BUY | 2019-05-16 | 2019-05-20 | $0.96 | $24K | -5.9% | -19.0% | -32.8% |
| MTNB | BUY | 2017-09-07 | 2017-09-07 | $1.30 | $130K | -10.1% | -2.2% | +4.3% |
| VRUS | SELL | 2011-05-03 | 2011-05-05 | $99.04 | $4.0M | N/A | N/A | N/A |
| SVNT | SELL | 2008-05-02 | 2008-05-06 | $23.92 | $239K | N/A | N/A | N/A |
| SVNT | SELL | 2008-04-01 | 2008-04-03 | $21.50 | $215K | N/A | N/A | N/A |
| SVNT | SELL | 2008-03-03 | 2008-03-05 | $22.89 | $229K | N/A | N/A | N/A |
| SVNT | SELL | 2008-02-01 | 2008-02-05 | $19.65 | $197K | N/A | N/A | N/A |
| SVNT | SELL | 2008-01-02 | 2008-01-04 | $23.92 | $239K | N/A | N/A | N/A |
| SVNT | SELL | 2007-11-28 | 2007-11-30 | $14.14 | $127K | N/A | N/A | N/A |
| SVNT | SELL | 2007-10-10 | 2007-10-11 | $15.11 | $76K | N/A | N/A | N/A |
| SVNT | SELL | 2007-10-05 | 2007-10-09 | $15.36 | $192K | N/A | N/A | N/A |
| SVNT | SELL | 2007-10-03 | 2007-10-05 | $15.52 | $39K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.